| ¿µ¹® | obsessive-compulsive disorder | ÇÑ±Û | °¹Ú¹ÝÀÀ¼º Àå¾Ö |
|---|---|---|---|
| ¼³¸í | °¹Ú»ç°í(obsession)Àº ¹Ýº¹µÇ´Â »ç°í¸¦ ¸»Çϸç, °¹ÚÇàÀ§(compulsion)´Â ¹Ýº¹µÇ´Â ÇൿÀ» ¸»ÇÑ´Ù. Áï ¹Ýº¹µÇ´Â »ç°í¿¡ µû¶ó ¹Ýº¹ÀûÀÎ ÇൿÀ» ¼öÇàÇÏ´Â Àå¾Ö¸¦ ¸»ÇÑ´Ù. À̶§ ¹Ýº¹ÀûÀÎ »ç°í´Â ÀÌ·ÐÀûÀ¸·Î ÀÌÇØµÇÁö ¾Ê´Â °æ¿ì°¡ ¸¹°í, º»Àεµ ÀÌ·± »ç°í°¡ ÀÌÇØµÇÁö ¾Ê´Â´Ù´Â »ç½ÇÀ» ¾Ë°í °íÄ¡·Á°í ÇÏÁö¸¸, Àß µÇÁö ¾Ê´Â´Ù. ¶ÇÇÑ °è¼ÓÀûÀ¸·Î ÀÌ·± »ç°í¿¡ µû¸¥ ¹Ýº¹ÀûÀÎ ÇൿÀ» Çϸç, ÀÌ·± ÇൿÀ» ¼öÇàÄ¡ ¾ÊÀ» ½Ã, º»ÀÎÀÇ ÀÇÁö¿Í ¹«°üÇÏ°Ô ¸÷½Ã ºÒ¾ÈÇØÇϰí, ÃÊÁ¶ÇØÇÑ´Ù. |
||
| ¿µ¹® | panic disorder | ÇÑ±Û | °øÈ²Àå¾Ö |
|---|---|---|---|
| ¼³¸í | ¹Ýº¹µÇ´Â °øÈ²¹ßÀÛ(panic attack: °©ÀÛ½º·± °øÆ÷»óÅÂÀÇ ¹ßº´)°ú ½Å°æ°ú¹ÎÀ» ³ªÅ¸³»´Â °æ¿ì¸¦ ¸»ÇÔ. °øÈ²¹ßÀÛÀº ´Üµ¶À¸·Î ÀϾ±âº¸´Ù´Â ¿À·£ ±äÀå»óÅ¿¡¼ ÁÖ±âÀûÀ¸·Î ÀϾ´Â Çö»óÀ¸·Î º¸ÀδÙ. °øÈ²¹ßÀÛÀÇ Áõ»óÀº ±Þ°ÝÇÑ ÀÚÀ²½Å°æÀÚ±ØÁõ»óÀ¸·Î È£Èí°ï¶õ, ½ÉÀå¹Úµ¿Ç×Áø, ÈäºÎÅëÁõ, ÈäºÎ¾Ð¹Ú°¨, Áú½Ä°¨, Çö±âÁõ, ºÒ¾ÈÁ¤ÇÑ ´À³¦ µîÀÌ´Ù. ´ë°³ °©ÀÚ±â ÀϾ ¼öºÐµ¿¾È Áö¼ÓÇß´Ù°¡ ¼Ò½ÇµÇ´Â °ÍÀÌ º¸ÅëÀÌ´Ù. µå¹°°Ô´Â ¼ö½Ã°£ Áö¼ÓµÇ±âµµ ÇÑ´Ù. °øÈ²¹ßÀÛÀº ÁÖ±âÀûÀ¸·Î ¹Ýº¹µÇ¸é¼ ¸¸¼ºÈÇÏ´Â °æÇâÀÌ ¸¹´Ù. ½Å°æ°ú¹ÎÀº °øÈ²¹ßÀÛÀÌ ¾ø´Â ½Ã±âÀÇ Áõ»óÀÌ´Ù. °¨´çŰ ¾î·Á¿î °øÈ²¹ßÀÛ¿¡ ´ëÇÑ ¿¹±âºÒ¾È(±× ÀÏÀÌ ÀϾÁö ¾ÊÀ»±î ÇÏ´Â ´À³¦ ¶§¹®¿¡ ¿À´Â ºÒ¾È)ÀÌ ÀÖ°í ±× ¶§¹®¿¡ Á¶½É½º·¯¿öÁö°í ÁÖÀ§¸¦ »ìÇǴ ŵµµµ ³ªÅ¸³ª¼ ½Å°æÀº ±Øµµ·Î ³¯Ä«·Î¿öÁø´Ù. °øÆ÷Àå¾Ö¿¡¼µµ ÀÌ·± °øÈ²¹ßÀÛÀÌ ¿Ã ¼ö ÀÖÀ¸³ª, ÀÌ °æ¿ì´Â Ưº°ÇÑ ´ë»óÀ̳ª »óȲÀÌ ÀÖ´Â °Í¿¡ ¹ÝÇØ °øÈ²Àå¾Ö´Â ÀÌ·± Ưº°ÇÑ »ç°Ç¾øÀÌ ÁÖ±âÀûÀ¸·Î ¹ß»ýÇÑ´Ù. Ä¡·á´Â Ç׺ҾÈÁ¦¿Í ¶§·Î´Â Ç׿ì¿ïÁ¦¸¦ »ç¿ëÇÑ´Ù. |
||
| ¿µ¹® | antisocial personality disorder | ÇÑ±Û | ¹Ý»çȸÀûÀΰÝÀå¾Ö |
|---|---|---|---|
| ¼³¸í | Áö¼ÓÀûÀ¸·Î ±×¸®°í ¸¸¼ºÀûÀ¸·Î ¹Ý»çȸÀûÀÎ ÇൿÀ» ÇÏ´Â Á¤½Å°úÀû º´. ´Ù¸¥ »ç¶÷¿¡°Ô Áø½Ç¼ºÀÌ ¾ø°í ´Ù¸¥ »ç¶÷ÀÇ ±Ç¸®³ª ÇÇÇØ¿¡´Â ÀüÇô ¹«°¨°¢ÇÏ°í ´ÜÁö ÀÚ½ÅÀÇ Ãæµ¿°ú ¿å±¸¿¡ ÀÇÇØ¼ ÇൿÀ» ÇÑ´Ù. ÀÚ½ÅÀÇ ½Ç¼ö¿¡ ´ëÇØ¼ ´Ù¸¥ »ç¶÷ÀÌ Ãæ°íÇÏ´Â °ÍÀ» ÂüÁö¸øÇϰí Ç×»ó ÀÚ½ÅÀÇ ¸¶À½´ë·Î¸¸ ÇÑ´Ù. |
||
| ¿µ¹® | anxiety disorder | ÇÑ±Û | ºÒ¾ÈÀå¾Ö |
|---|---|---|---|
| ¼³¸í | ½É¸®Àû ºÒ¾ÈÁ¤À̳ª ºÒ¾È µîÀ» ÁÖ Æ¯Â¡À¸·Î ÇÏ´Â Á¤½Å°úÀû º´ÅÂ. ´ëÇ¥ÀûÀÎ ¿¹·Î´Â °øÆ÷Áõ(phobia)¿Í °øÈ²Àå¾Ö(panic disorder), Àü¹ÝÀû ºÒ¾ÈÀå¾Ö(generalized anxiety disorder) µîÀÌ ÀÖ´Ù. °øÆ÷ÁõÀ̶õ ƯÁ¤ÇÑ Àå¼Ò³ª »óȲ¿¡ ´ëÇØ¼ º´ÀûÀÎ ºÒ¾ÈÀ» ´À³¢´Â °ÍÀ¸·Î ±¤Àå°øÆ÷Áõ(agoraphobia): Ź Æ®ÀÎ °ø°£À» ¹«¼¿öÇÔ. »çȸ°øÆ÷Ãþ(social phobia): ´Ù¸¥ »ç¶÷¾Õ¿¡ ¼´Â °ÍÀ» ¹«¼¿ö ÇÔ. °í¼Ò°øÆ÷Ãþ(acrophobia): ³ôÀº °÷¿¡ °¡´Â °ÍÀ» ¹«¼¿öÇÔ. ÁøÆó°øÆ÷Áõ(claustrophobia): ¹ÐÆóµÈ °ø°£À» ¹«¼¿öÇÔ. µ¿¹°°øÆ÷Áõ(zoophobia): µ¿¹°À» º´ÀûÀ¸·Î ¹«¼¿öÇÔ µîÀ» Æ÷ÇÔÇÑ´Ù. °øÈ²Àå¾Ö(panic disorde)¶õ ¿ÜºÎÀÇ À§ÇèÇÑ ÀÚ±ØÀÌ ¾ø´Âµ¥µµ ºÒ±¸ÇÏ°í °©Àڱ⠱ؽÉÇÑ °øÆ÷¸¦ ´À³¢´Â °ÍÀ» ¸»ÇÑ´Ù. ´ë°³ ½ÉÀåÀÌ ½ÉÇÏ°Ô ¶Ù°Å³ª ½ÄÀº ¶¡À» È긮°í, ½Ç½Å, È£Èí°ï¶õ µîÀÇ Áõ»óÀ» µ¿¹ÝÇÑ´Ù. Àü¹ÝÀû ºÒ¾ÈÀå¾Ö(generalized anxiety disorder)¶õ 1°³¿ùÀÌ»ó Áö¼ÓÀûÀÎ ºÒ¾ÈÀ» ´À³¢´Â °ÍÀ» ¸»ÇÑ´Ù. ´ë°³ »ç¼ÒÇÑ ÀÏ»óÀÇ ÀÏ¿¡ ´ëÇÑ ºÒ¾ÈÀ» ´À³¢¸ç, ºÒ¾ÈÀÇ ´ë»óÀÌ ¾ø´Â °æ¿ì¿¡´Â ¾ðÁ¦ ºÒ¾ÈÀ» ´À³¥Áö ¸ð¸¥´Ù´Â ºÒ¾È°¨(¿¹±âºÒ¾È)À» È£¼ÒÇÑ´Ù. ´ë°³ ¼è¾à, ¾îÁö·¯¿ò, ¼Õ¶³¸², ¶¡À» È긮´Â µîÀÇ ½ÅüÀû Áõ»óÀ» µ¿¹ÝÇÑ´Ù. |
||
| ¿µ¹® | cyclothymic disorder | ÇÑ±Û | ¼øÈ¯¼ºÀå¾Ö |
|---|---|---|---|
| ¼³¸í | ¿ÜºÎÀڱؿ¡ ÀÇÇØ¼ º¯ÈÇÏÁö ¾Ê´Â Áö¼ÓÀûÀÎ ¸¶À½ÀÇ »óÅÂÀÎ ±âºÐ(mood)ÀÇ ÀÌ»óÀÌ ÀÖ´Â Á¤µ¿Àå¾Ö(affective disorder, mood disorder)ÀÇ ÇÑ Á¾·ù. Á¤µ¿Àå¾ÖÀÇ ´ëÇ¥ÀûÀÎ º´À¸·Î´Â ¿ÜºÎÀÇ Àڱؿ¡ °ü°è¾øÀÌ Áö¼ÓÀûÀ¸·Î ±âºÐÀÌ ¿ì¿ïÇÑ ¿ì¿ïº´(depression)°ú Áö¼ÓÀûÀ¸·Î ¿ÜºÎÀÇ Àڱؿ¡ °ü°è¾øÀÌ ±âºÐÀÌ µé¶ß´Â Á¶º´(mania)ÀÌ ÀÖ´Ù. À̱ؼº Àå¾Ö¶õ ¿ì¿ïº´°ú Á¶º´ÀÌ ÁÖ±âÀûÀ¸·Î ¹Ýº¹µÇ´Â Á¤½Åº´°ú Á¶º´¸¸ ÀÖ°í ¿ì¿ïº´Àº ¾ø´Â °æ¿ì¸¦ ¸ðµÎ Æ÷ÇÔÇÏ´Â °³³äÀÌ´Ù. Áï ¿ì¿ïº´ÀÇ À¯¹«¿¡ °ü°è¾øÀÌ Á¶º´ÀÌ ÇѹøÀÌ¶óµµ ÀÖ´Â °æ¿ì À̰ÍÀ» À̱ؼº Àå¾Ö¶ó°í ÇÑ´Ù. ¼øÈ¯¼ºÀå¾Ö¶õ À̱ؼº Àå¾Ö¿Í °°ÀÌ ÈïºÐ°ú ¿ì¿ïÀÇ »óŰ¡ ÁÖ±âÀûÀ¸·Î ¹Ýº¹ÇÏ´Â °ÍÀº ¸¶Âù°¡ÁöÀÌÁö¸¸ ÈïºÐÀ̳ª ¿ì¿ïÀÇ »óŰ¡ ÈξÀ °æÇÑ °æ¿ì¿¡ »ç¿ëµÇ´Â ¸»ÀÌ´Ù. |
||
| CD | cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise... |
|---|---|
| STANDOUT | soft thresholding and depth cueing of unspecified techniques |
| URD | unspecified respiratory disease; upper respiratory disease |
| BD | barbital-dependent; barbiturate dependence; base deficit; base of prism down; basophilic degeneratio... |
| DD | dangerous drug; data definition; day of delivery; degenerated disc; degenerative disease; delusional... |
| LDL-C | lipoprotein cholesterol and low-density lipoprotein cholesterol |
|---|---|
| ADME | Absorption, distribution, metabolism, and excretion |
| CAM | Crassulacean Acid Metabolism |
| FPM | First pass metabolism |
| IEM | Inborn Errors of Metabolism |
| a1-lipoprotein | A lipoprotein fraction of relatively low molecular weight, high density, rich in phospholipids, and found in the a1-globulin fraction of human plasma. (05 Mar 2000) |
|---|---|
| b1-lipoprotein | A lipoprotein fraction of relatively high molecular weight, low density, rich in cholesterol, and found in the beta-globulin fraction of human plasma. (05 Mar 2000) |
| basal metabolism | <biochemistry, biology> Heat production, or its measurement, of an organism at the lowest level of cell chemistry in an inactive, awake, fasting state. It may be determined directly by means of a calorimeter or indirectly by calculating the heat production from an analysis of the end products of oxidation within the organism or from the amount of oxygen utilised. (27 Jun 1999) |
| calcium metabolism | A set of biochemical processes which act to keep the level of calcium in the blood at a constant level, with enough around to build bones and teeth. (09 Oct 1997) |
| calcium metabolism disorders | Disorders in the processing of calcium in the body: its absorption, transport, storage, and utilization. (12 Dec 1998) |
| carbohydrate metabolism | <biochemistry> The breakdown of starches and sugars into smaller units that can be used by the body for energy. (27 Sep 1997) |
| receptors, lipoprotein | Cell surface proteins that bind lipoproteins with high affinity. Lipoprotein receptors in the liver and peripheral tissues mediate the regulation of plasma and cellular cholesterol metabolism and concentration. The receptors generally recognise the apolipoproteins of the lipoprotein complex, and binding is often a trigger for endocytosis. (12 Dec 1998) |
| very low density lipoprotein | <biochemistry> A lipoprotein substances (combination of a fat and a protein) which acts as a carrier for cholesterol and fats (particularly triglycerides) in the bloodstream. Elevations in very low density lipoprotein in the bloodstream are associated with an increased risk of atherosclerosis and coronary artery disease. Acronym: VLDL (18 Nov 1997) |
| respiratory metabolism | The exchange of respiratory gases in the lungs, oxidation of foodstuffs in the tissues, and production of carbon dioxide and water. (05 Mar 2000) |
| metabolism | <biochemistry> The sum of all the physical and chemical processes by which living organised substance is produced and maintained (anabolism) and also the transformation by which energy is made available for the uses of the organism (catabolism). Origin: Gr. Metaballein = to turn about, change, alter (18 Nov 1997) |
| phosphorus metabolism disorders | Disorders in the processing of phosphorus in the body: its absorption, transport, storage, and utilization. (12 Dec 1998) |
| water of metabolism | The water formed in the body by oxidation of the hydrogen of the food, the greatest amount being produced in the metabolism of fat (about 117 g/100 g of fat). Synonym: water of combustion. (05 Mar 2000) |
| multiple lipoprotein-type hyperlipidaemia | <biochemistry> Inherited as a defective gene, this disorder is characterised by elevations in serum cholesterol and/or triglycerides. There are often multiple types of lipoproteins (LDL) elevated in one family. This condition is associated with an increased risk of cardiovascular disease. Origin: Gr. Haima = blood (27 Sep 1997) |
| Crassulacean acid metabolism | <plant biology> Physiological adaptation of certain succulent plants, in which carbon dioxide can be fixed (nonphotosynthetically) at night into malic and other acids. During the day the carbon dioxide is regenerated and then fixed photosynthetically into the Calvin Benson cycle. This adaptation permits the stomata to remain closed during the day, conserving water. (18 Nov 1997) |
| primary metabolism | Metabolic processes central to most cells; e.g., biosynthesis of macromolecules, energy production, turnover, etc. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|